Appointment of Nominated Adviser and Joint Broker
Cambridge Cognition Holdings plc has appointed Cavendish Capital Markets Limited as its Nominated Adviser and Joint Broker with immediate effect, while Singer Capital Markets will continue as Joint Corporate Broker. The company also disclosed that its Chairman, Steven Powell, was a director of Ribonexus SAS, which entered court-ordered liquidation in April 2024 and remains in liquidation, and previously resigned from LCC Therapeutics before it entered creditors voluntary liquidation in October 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your COG notes
Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces the appointment of Cavendish Capital Markets Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.
Singer Capital Markets remain in their role as Joint Corporate Broker.
The Company confirms the following director disclosures pursuant to AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.
Steven Powell (Chairman)
Ribonexus SAS, a company which Steven Powell is a director of, entered into a court-ordered liquidation in April 2024. The Company is currently still in liquidation.
Steven was previously a director of LCC Therapeutics, resigning on 17 June 2025. After he had left employment, the company appointed an administrator and later entered into a creditors voluntary liquidation on 16 October 2025. The Company is currently still in liquidation.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.